Humana AB's stock jumped dramatically on Monday following a recommended acquisition proposal from rival care company Ambea. The bid places Humana's enterprise value at roughly 2.96 billion Swedish crowns, equivalent to about $304 million, and prompted a substantial rise in the share price in early Stockholm trade.
By 07:26 GMT, Humana's shares had climbed about 25% to SEK 61.40 per share in Stockholm. The market reaction reflected investor attention to the terms of Ambea's offer as well as the potential resolution of a pending legal matter that factors into the deal's full payout.
Under the terms announced, Ambea is proposing a mix of cash and stock to Humana shareholders: SEK 20 in cash plus 0.305 Ambea shares for each Humana share held. That combination places a headline value on Humana of SEK 62.30 per share, representing a near 27% premium to Humana's closing price on June 26.
The offer also carries a contingent value right worth up to SEK 4.36 per Humana share. The contingency is explicitly linked to the outcome of Humana's ongoing legal case against the Swedish state, which concerns a revoked personal-assistance licence. Payment of the contingent amount would therefore depend on the resolution of that legal proceeding.
Humana's board has given unanimous support to Ambea's proposal. In addition, shareholders owning approximately 42% of Humana's shares have already committed to accept the offer, providing a significant level of early backing for the transaction.
Ambea has indicated that, once the acquisition completes, it intends to divest Humana's Personal Assistance Sweden business. The company has not disclosed further detail about the timing or structure of any planned sale within the terms presented.
Market participants will watch two primary developments going forward: the legal case tied to the contingent payment and the progress of remaining shareholder acceptances required to complete the transaction. Both items are central to whether the full value of the offer materializes for Humana shareholders and to the ultimate structure of the combined group after any divestment.
Market reaction snapshot:
- Shares rose roughly 25% to SEK 61.40 by 07:26 GMT in Stockholm trading.
- Offer values Humana at SEK 62.30 per share, a near 27% premium to the June 26 close.
- Contingent value right up to SEK 4.36 per share dependent on legal outcome.